Guidance on contraception for women aged over 40 years: response from the CEU.

14:16 EDT 25th October 2014 | BioPortfolio

Summary of "Guidance on contraception for women aged over 40 years: response from the CEU."

No Summary Available

Affiliation

Consultant in Sexual and Reproductive Health, NHS Grampian, Square 13 Centre for Sexual and Reproductive Health, Aberdeen Maternity Hospital, Aberdeen, UK; sue.brechin@nhs.net.

Journal Details

This article was published in the following journal.

Name: The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal Colle
ISSN: 1471-1893
Pages: 125

Links

PubMed Articles [22554 Associated PubMed Articles listed on BioPortfolio]

'As many options as there are, there are just not enough for me': Contraceptive use and barriers to access among Australian women.

Objective A comprehensive life course perspective of women's experiences in obtaining and using contraception in Australia is lacking. This paper explores free-text comments about contraception provid...

Emergency contraception: a review.

Emergency contraception use is safe for women of all ages, and there are no medical contraindications to its use. The copper intrauterine device is the most effective form, and ulipristal acetate is t...

Contraception, punishment and women who use drugs.

In light of the recent debate on the use of financial incentives to promote long-acting contraception and sterilisation among women who use illicit drugs we discuss attitudes to contraception, pregnan...

Factors predicting uptake of long-acting reversible methods of contraception among women presenting for abortion.

Objective: To examine the uptake of long-acting reversible contraceptive (LARC) methods after abortion among women seeking abortions through a major Australian abortion provider. Design and setting: C...

Thrombotic risk of contraceptive transdermal patches and the contraceptive vaginal ring.

The annual risk of venous thrombosis has been estimated at 5 to 10 cases per 100 000 women aged 15 to 44 years who are not using hormonal contraception.The risk increases with age for all women. Combi...

Clinical Trials [4612 Associated Clinical Trials listed on BioPortfolio]

Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia

In this study, 66 HIV-infected women who desire contraception will be randomly assigned to use either an IUD or Depo Provera, and will be followed for six months. The study is intended to...

Computer-Assisted Provision of Reproductive Health Care

This project seeks to demonstrate that computer kiosks in a clinic waiting room can improve access to hormonal contraception and screening for sexually transmitted infections. The study wi...

Study of Self or Clinic Administration of DepoProvera

Depot medroxyprogesterone acetate (DepoProvera) is an acceptable form of contraception for many women. However, difficulty in access may cause many women to discontinue use, often without ...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years

A study to determine the efficacy of MK0476 in the Treatment of Asthmatic Patients Aged 2 to 5 Years.

Medical and Biotech [MESH] Definitions

Purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually GAMMA-GLOBULINS. This syndrome often occurs on the legs of women aged 20 to 40 years.

A person 65 through 79 years of age. For a person older than 79 years, AGED, 80 AND OVER is available.

The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

A person 80 years of age and older.

Methods of contraception in which physical, chemical, or biological means are used to prevent the SPERM from reaching the fertilizable OVUM.

Search BioPortfolio:
Loading
Advertisement

Relevant Topic

Women's Health
Latest News Clinical Trials Research Drugs Reports Corporate
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Advertisement